Earnings growth masks revenue stall; margin pressure ahead under bank competition
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Q1 on-track on disbursement (14.5% vs 15% target) and credit cost guidance. But 5-year lag in growth/margins vs peers unresolved; audit friction on restructured account timeline clouds governance.
Neutral
next 1–2 quarters
Cautiously Optimistic
multi-year
Solid earnings growth (+9.9% PAT) and improving credit quality (Stage 3 2.14%, down 48 bps) offset by structural margin compression (NIM -10 bps to 2.58%) and anemic portfolio growth (4% AUM). Management maintaining FY27 guidance (NIM 2.6%, credit cost 10-15 bps) but at cautious lower end, explicitly hedging margin pressure from bank competition. Key risk: portfolio growth acceleration dependent on unproven product diversification and tech investments; history of 5-year underperformance vs peers raises execution doubt.
₹7082.6 Cr
Revenue · −2.3% YoY₹1499 Cr
Reported PAT · +9.9% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Disbursement growth 14.5% in line with 15% guidance
METDisburse ₹15,014 Cr vs ₹13,116 Cr YoY = 14.5%; achieved near-guided 15% quarterly target
NIM 2.58%, within guidance of 2.6-2.7%
METQ1 NIM 2.58%, 2 bps below lower end of guided 2.6% range; margin compression vs 2.68% prior year
Asset quality improved; Stage 3 at 2.14% from 2.62%
METGNPA ratio 2.14% vs 2.62% YoY; 48 bps improvement confirmed
Growth momentum reflected in 14.5% disbursement growth
OVERSTATEDDisbursement growth strong, but AUM portfolio only +4% YoY (₹322,098 Cr vs ₹309,587 Cr); lower portfolio base growth offsets disburse strength
Cost of funds down 22 bps YoY provides structural benefit
METCoF at 7.28% vs 7.50% YoY (22 bps reduction); but incremental CoF at 7.06% vs portfolio average, suggesting limited further compression ahead
Earnings quality
What changed since the last call
NIM guidance at risk
DowngradeQ1 NIM 2.58% (2 bps below 2.6% lower end); incremental yield 8.25% vs portfolio 9.12% = 87 bps compression ahead. Management explicitly calling FY27 a 'tug of war' between growth and margins; acknowledges 'challenging' path.
AUM growth reset lower
DowngradePrior implied 'double digit' AUM growth → explicit 8-10% guidance in Q1 call; reflects 5-year track record (4% growth) and competitive intensity. Management defending 4% Q1 by citing large base (₹3 lakh Cr), but growth significantly lags Bajaj/CanFin (20-25%).
Margin pressure mechanisms clarified
NeutralRate cuts from RBI (25 bps cut in April reflected across book); BT out rising (₹1,500 Cr net this Q vs ₹1,200-1,300 Cr typically); cost of borrowing expected to rise 3-4 bps. Management strategy: product mix shift to OHL (150 bps higher yield) growing 20%, but IHL still 84% of book.
Disbursement guidance on track
NeutralQ1 delivered 14.5% vs guided 15%; Q2 targeting 15% again; full-year 10-12% maintained. No change from start-of-year guidance; quarterly volatility expected (April at 21%, May-June lower).
Credit cost guidance maintained
NeutralQ1 at -5 bps (driven by ₹180 Cr NARCL sale and ₹37 Cr write-off recoveries); full-year 10-15 bps guidance stands. Management confident on <2% GNPA for full year (vs Q1 2.14%). Recoveries accelerating from legacy loans in resolution.
The Q&A
Analysts pressed hard on growth lag (5-year underperformance vs peers), margin sustainability (yield gap 87 bps), and tech payoff timeline. Management held but defensive: acknowledged history, explained competitive constraints with banks, but offered no concrete acceleration catalyst. Audit friction on restructured account timing visible.
Growth vs margin trade-off — Avinash Singh, Emkay Global
PartialAcknowledged history; noted disbursement growth now at 15% (vs historical <10%) is improvement. Product diversification (LAP/LRD) gaining traction; direct assignment/co-lending coming Q2. Will take time to show in portfolio.
Cost increase driver — Gaurav Khandelwal, JPMorgan
Answered₹22 Cr gratuity provision one-off from G-Sec yield increase. IT spend hasn't happened yet; will come Q2-Q4. Hiring minimal impact.
NPA accounting change impact — Kunal Shah, Citigroup
Answered₹164 Cr P&L entry = ₹132 Cr ECL + ₹32 Cr recovery. Restructured ₹500 Cr account not yet in Q1 (auditor delay); expected Q2/Q3.
Margin sustainability math — Abhijit Tibrewal, Motilal Oswal
PartialOHL portfolio (150 bps higher yield) growing 20% vs IHL 15%. Hopes diversification compensates; expects borrowing cost pressure 3-4 bps max.
Developer finance expansion — Abhishek, HSBC
PartialTransactional; evaluated case-by-case. Prior year sanctions ₹5,000 Cr don't guarantee disburse if rates unacceptable (<8% rejected as unprofitable). Target ₹4,000 Cr, expecting ₹7-8,000 Cr.
External CEO/leadership changes — Rishi Mody, Mody Advisory
DodgedDenied ever saying this; firmly rejected rumor. No external CEO search.
Project RED and tech benefits — Rishi Mody, Mody Advisory
PartialRED complete (2023-24 LMS/LOS overhaul); now integrating apps. STP process live (₹960 Cr via HOMY app Q1). Data lake-house project tendering. Acknowledged Bajaj/CanFin ahead tech-wise; will catch up.
Written-off account recovery outlook — Rishi Mody, Mody Advisory
Answered₹3,000 Cr in technical write-off status; ₹37 Cr recovered Q1. Targeting ₹500-600 Cr FY27; ₹2,000 Cr over 2 years. Loans in SARFAESI, DRT, NCLT, OTS stages.
Disbursement target volatility — Arun Antony, JM Financial
AnsweredOne month not indicative. Quarterly guidance 15%; Q1 at 14.5% is on track. Month-to-month volatility expected (July good, August lower, etc.).
Guidance
No explicit revenue target; disbursement growth 10-12% FY27
HighQ1 at 14.5% growth (ahead of 15% target), momentum expected to continue. Disbursement proxy for revenue traction given asset base.
NIM 2.6% (lower end of 2.6-2.7%) for FY27
MediumQ1 at 2.58% (2 bps below lower end); incremental yield 8.25% vs portfolio 9.12% creates 87 bps compression headwind. Management hedged: diversification to OHL (150 bps higher yield) growing 20% expected to partially offset.
Significant IT spend in Q2-Q4; data lake-house RFP tendering complete
MediumProject RED LMS/LOS complete (2023-24). STP process 4 months operational (₹960 Cr disburse). Data lake with AI integration critical near-term spend. No quantified capex amount disclosed.
Risks the call surfaced
Margin compression
HighIncremental disbursement yield 8.25% vs portfolio yield 9.12% = 87 bps gap. As new advances reprice old book, portfolio yield trending down. Management targeting 2.6% NIM but structural headwind.
Portfolio growth lag
HighAUM growth only 4% YoY vs peer growth 20-25% (Bajaj/CanFin). 5-year track record of <10% growth. Large base (₹3 lakh Cr) cited as excuse, but fundamental execution challenge evident.
Refinance risk
Medium₹17,000 Cr debt maturing FY27 at 7.38% avg cost. Incremental borrowing cost at 7.06%, but CFO noted market rates 'slightly on higher side.' Cost of funds could increase 3-4 bps on cumulative basis.
Execution on tech investments
MediumProject RED, STP process, and data lake-house under development. STP only 4 months live; no quantified payoff on cost reduction, credit quality improvement, or growth acceleration. Heavy OpEx expected Q2-Q4; uncertain timeline.
Developer finance expansion
MediumExpanding developer finance (₹872 Cr Q1, targeting ₹4,000 Cr FY27) after weak track record. Large positions (₹3,000 Cr technical write-off) still in recovery. Credit policy undergoing revision to expand beyond triple-B rated builders.
Management
Score 6/10. Open on challenges but defensive on execution. Acknowledged 5-year growth/margin lag directly; explained constraints (bank competition, rate cuts). Evasive on external CEO rumor (flat denial). Accounting change (NPA recovery reclassification) well-explained. Audit friction on restructured account timing suggests governance friction. Mixed track record. Q1 on-track on disbursement (14.5% vs 15%) and NIM (2.58% vs 2.6% guided). But 5-year AUM growth lag (4% avg vs peer 20-25%) is material execution miss. PAT growth +9.9% solid, but driven by credit cost relief, not operational improvement.
1 · Q2 FY27
Restructured ₹500 Cr account upgrade; provision release expected
2 · Q2 FY27
Direct assignment & co-lending policy launch; incremental margin business
3 · H2 FY27
Data lake-house AI project tendering (contract award imminent)
Key risk: portfolio growth acceleration dependent on unproven product diversification and tech investments; history of 5-year underperformance vs peers raises execution doubt.
LIC Housing Q1: consolidated PAT ₹1,499 Cr, up ~10% YoY — but a ₹164 Cr write-back does the lifting
PAT +9.9% YoY · revenue -2.31% · margins expanding
₹7,082.59 Cr
-2.31% YoY
₹1,499.03 Cr
+9.9% YoY
21.16%
+2.4pp YoY
₹27.25
LIC Housing Finance opened FY27 with consolidated net profit of ₹1,499.03 Cr, up 9.9% YoY (₹1,364 Cr) and broadly flat sequentially (+0.4% vs ₹1,492.62 Cr), on revenue from operations of ₹7,082.59 Cr that actually slipped ~2.3% YoY and ~1.8% QoQ. The headline profit growth is not a topline story — it is almost entirely a credit-cost story. Impairment on financial instruments swung to a ₹164.23 Cr WRITE-BACK this quarter from a ₹121.67 Cr charge a year ago, a ~₹286 Cr pre-tax tailwind. Strip that swing out and underlying PAT is roughly flat-to-slightly-negative YoY (~-5% adjusted), so the print reads "steady," not "strong," despite the optics.
Q1 FY-2027 vs prior quarters
The margin trajectory reflects the same mechanic: net profit margin expanded to ~21.2% (standalone 21.06%) from 18.81% a year ago, but the expansion sits on the provisioning line, not on net interest income — interest income was flat-to-lower at ₹7,033.56 Cr (consolidated) and finance costs eased to ₹4,946.35 Cr. The write-back is grounded in genuinely better asset quality: gross Stage-III (GNPA) improved to 2.14% from 2.62% a year ago and NNPA to 1.12%, with PCR at 48.12%. Debt-equity eased to 6.59x (from 7.37x) and net worth rose to ₹42,807.71 Cr.
The stock went into the print at ₹540.9, down 2.4% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 2 consecutive quarters.
Standalone tells the same story with a marginally softer bottom line — PAT ₹1,488.32 Cr, EPS ₹27.06 vs consolidated EPS ₹27.25 — the divergence (subsidiaries LICHFL Care Homes, Financial Services, AMC and Trustee plus associate LIC MF AMC) is immaterial, under ~1% at the PAT level, so the two do not tell different stories. Management gives no formal guidance and there is no prior concall on record; street consensus for the quarter is not publicly available. The quarter's corporate calendar — the Aug 21 record date and FY26 dividend, the 37th AGM on Aug 28, and Sandeep Kumar's appointment as COO — is procedural and unrelated to the print. The read into next quarter is whether the provisioning tailwind persists or reverses, because core lending revenue is not currently growing.
W1
Whether the ₹164 Cr provisioning write-back persists or reverses next quarter — it, not NII, drove the +10% print
W2
Interest income re-acceleration: ₹7,033.56 Cr was flat-to-lower YoY, so core topline needs to turn
W3
GNPA trajectory from 2.14% — further improvement sustains write-backs; any uptick removes the tailwind
Earnings Growth Masks Revenue Stall and Structural Margin Squeeze
PAT rose 9.9% but revenue fell 2.3%, driven by credit cost relief rather than operational gain. Meanwhile, NIM compressed 10 bps and portfolio growth lags peers by a wide margin — margins under structural pressure.
+9.9%
₹1,499 Cr YoY
-2.3%
₹7,083 Cr YoY
-10 bps
2.58% vs 2.68%
-48 bps
2.14% vs 2.62%
The headline reads 9.9% profit growth. But look beneath: revenue is flat, net interest margin has shrunk 10 basis points, and the portfolio is growing at 4% — half the rate of peers. The PAT gain is real, but it comes from credit cost relief (the benefit of lower impairments from improving asset quality), not from stronger operations. On the margin front, management has a problem they can't hide: new loans are being disbursed at 8.25% yield while the existing portfolio averages 9.12%. That 87-basis-point gap will squeeze NIMs as the book reprices over the year. Management knows it — they've hedged their guidance and called the outlook 'challenging.'
Where PAT growth really came from
Net profit jumped to ₹1,499 Cr from ₹1,360 Cr, a 9.9% gain. But the organic story is murkier. Revenue fell 2.3% to ₹7,083 Cr. The profit beat came from two sources: (1) lower credit costs — Q1 recorded a negative 5 basis point credit cost (a benefit, not an expense) thanks to ₹540 Cr in recoveries from stage 3 accounts and a ₹180 Cr sale of NPAs to NARCL; and (2) accounting refinements. The ₹37 Cr reclassification of NPA recoveries from other income into the impairment provision line (an audit-requested change) improves governance but masks the raw other-income trend. Neither is operational leverage. Real NIM — the spread that pays for the lending franchise — is under structural pressure.
Disbursement growth 14.5% in line with 15% guidance
₹15,014 Cr vs ₹13,116 Cr YoY = 14.5%; quarterly target 15% achieved near-guided
Supported
NIM 2.58%, within guidance of 2.6–2.7%
2.58%, 2 bps below lower end of 2.6% range; YoY compression 10 bps
Supported but at lower end
Asset quality improved; Stage 3 at 2.14% from 2.62%
GNPA ratio 2.14% vs 2.62% YoY; 48 bps improvement confirmed
Supported
Growth momentum reflected in 14.5% disbursement growth
Disbursement +14.5%, but AUM portfolio only +4% YoY; ₹1,500 Cr net balance transfer out offsets strength
Overstated
Cost of funds down 22 bps YoY provides structural benefit
CoF at 7.28% vs 7.50% YoY (22 bps reduction). But incremental CoF 7.06% vs portfolio avg — limited further compression ahead
Supported, but benefit capped
The margin squeeze, quantified
NIM fell from 2.68% to 2.58% — a 10-basis-point compression. This isn't noise. The root cause is plain: new disbursements in Q1 carried a yield of 8.25%, while the existing portfolio averages 9.12%. As the old book matures and reprices, that 87-basis-point gap will grind the portfolio yield downward. Management has acknowledged this explicitly, framing FY27 as a 'tug of war' between growth and margins.
Portfolio growth: the structural lag
AUM grew just 4% year-on-year to ₹3.22 lakh Cr. In isolation, 4% is not alarming. But in context, it's a red flag. Bajaj Housing and CanFin Homes are growing portfolios at 20–25%. LIC HFL's 5-year history shows growth lagging peers consistently — the company has underperformed in an industry with tailwinds. Part of the issue is portfolio maturity (a large base of ₹3 lakh Cr home loans naturally matures slower), but disbursement strength (14.5% growth) is not translating into portfolio expansion. The reason: ₹1,500 Cr flowed out via balance transfer and prepayment in Q1 alone. The franchise is not retaining or growing its client base at scale.
What changed on this call
NIM guidance reset — now explicitly at lower end (2.6%, not 2.7%) with 'challenging' outlook hedged
AUM growth guidance reset to 8–10% (vs. prior 'double-digit' expectation) — admits 5-year track record
Margin pressure mechanisms clarified — 87 bps yield gap, bank competition, rate cuts all articulated
Disbursement guidance maintained at 10–12% FY27; Q1 delivered 14.5%, on track
Developer finance expansion underway (₹872 Cr Q1, targeting ₹4,000 Cr FY27, expecting ₹7–8 Cr stretch)
Direct assignment & co-lending policy launching Q2 — new margin business coming
Earnings quality and audit friction
Four items flag the quality of reported numbers. (1) NPA recovery reclassification — ₹37 Cr moved from other income to impairment provision per auditor request; a governance cleanup that obscures one-off distortions. (2) Gratuity one-off — ₹22 Cr charge from G-Sec yield increase in Q1; management flagged as non-recurring. (3) Restructured account upgrade dispute — a ₹500 Cr account restructured in May 2025 should hit its 1-year anniversary in Q1 FY27 (now), but auditors are disputing the payment timing; expected upgrade Q2/Q3 creates asymmetric upside and suggests audit friction. (4) NPA sale — ₹180 Cr sold to NARCL for ₹140 Cr (₹40 Cr loss), clearly disclosed. The audit dispute is the most concerning: it signals governance friction between management and auditors on a material restructured account. When resolved, it will provide a one-time boost to provisions and equity.
How the street is reading it
The market's verdict came swift and harsh. On day 1 post-result, the stock fell 3.29% and never recovered. By day 5, it had shed 6.64%. The broader context: LICHF is now trading at ₹498.8, down 16.6% from its all-time high of ₹598.2. It sits below its 20-day, 50-day, and 200-day moving averages, with an RSI of 12 (oversold territory). Volume remains normal. This is not a panic liquidation but a systematic repricing. The market has absorbed the structural challenges — margin compression, growth lag — and marked down the stock accordingly.
The institutional positioning tells a story: neither FII nor DII has panic-sold; both have added marginally (FII +0.08pp, DII +0.13pp) in the most recent quarter. The promoter remains at 45.24%, unchanged. This suggests no loss of confidence at the top. Instead, it looks like a rational repricing — the market has priced in lower near-term NIM guidance, acknowledged the growth lag, and taken the stock down 16% from ATH to reflect a 'Hold' outlook rather than a 'Buy.'
The bull-bear ledger
Credit quality improving — Stage 3 down 48 bps to 2.14%, recoveries accelerating, targeting <2% GNPA for FY27
Disbursement momentum strong at 14.5%, highest in recent years; 15% target achievable
Cost of funds down 22 bps YoY; ₹17,000 Cr debt maturity refinance at lower rates is a tailwind
PAT growth +9.9% solid, with ROA improving 9 bps; earnings resilience despite revenue headwinds
Diversification underway — LAP/LRD (non-individual housing) growing 20%, direct assignment/co-lending launching Q2
Revenue stalled (-2.3% YoY) despite disbursement growth — margin compression swallowing top-line gains
NIM at 2.58%, 2 bps below guided lower end; structural headwind of 87 bps yield gap ahead
AUM growth only 4% vs. peers at 20–25%; 5-year lag unresolved; portfolio not retaining or growing at scale
Guidance maintained but at lower end with explicit hedges ('challenging' margins, 'tug of war' outlook)
Audit friction on restructured account and external CEO rumor denial suggest governance friction
Tech payoff unquantified — Project RED, STP, data lake heavy on investment, light on ROI timeline
Risks, ranked by severity
1 · Structural margin compression
The 87-basis-point gap between incremental yield (8.25%) and portfolio average (9.12%) will grind the portfolio yield lower over time. As the book reprices, NIM will drift from 2.58% toward the lower 2.5% range. Management's diversification into OHL (150 bps higher yield) is too small (still <5% of portfolio) to offset. This is the defining headwind of the year.
2 · Portfolio growth lag vs. peers
4% AUM growth vs. Bajaj/CanFin at 20–25% reflects a 5-year track record of underperformance. Large base (₹3 lakh Cr) is cited as a reason, but it doesn't excuse it. Prepayments (₹1,500 Cr net outflow Q1) and balance transfers are eating growth. Until the company proves it can expand faster, the growth story remains at risk.
3 · Refinance cost pressure
₹17,000 Cr debt matures in FY27 at 7.38% average cost. New borrowing is at 7.06%, but CFO noted market rates 'slightly on higher side.' Cumulative cost of funds could rise 3–4 bps if rates harden. On a ₹3 lakh Cr asset base, that's a material margin haircut.
4 · Developer finance risk
Expanding developer lending (₹872 Cr Q1, targeting ₹4,000 Cr FY27) after a ₹3,000 Cr technical write-off in the segment. New credit policy under board review; risk of underwriting deterioration as the company relaxes guardrails to hit growth targets. Lending at 10.5%+ to filter for risk, but the segment has a history of losses.
5 · Tech payoff unquantified
Project RED (LMS/LOS), STP (digital onboarding), and data lake-house AI (contract award pending) represent heavy capex commitments with uncertain ROI. STP is only 4 months old; no quantified payoff on cost reduction or credit quality uplift. If execution slips or outcomes disappoint, the OpEx drag will weigh on FY27–FY28 margins.
The debate
What to watch next
1 · Q2 restructured account upgrade
The ₹500 Cr account should officially graduate from restructured status in Q2–Q3 (audit timing permitting). Expected provision release could provide ₹50–100 Cr one-time equity boost and offset margin pressure optics. This is the most likely near-term positive catalyst.
2 · Direct assignment & co-lending policy launch (Q2)
New policy to diversify margins via assignment of loans and co-lending (eg. with banks). If priced at 150+ bps above IHL, could provide material margin uplift. Watch for first ₹500–1,000 Cr in new flows and pricing realization.
3 · Developer finance ramp and credit outcomes
Target ₹4,000 Cr FY27 (expecting ₹7–8 Cr stretch). New credit policy board approval in Q2. If realized, this becomes 2–3% of AUM and provides a margin cushion. But watch for credit quality (80+ bps spreads, 10.5%+ lending rates needed to offset risk) and any early-stage NPA signals.
4 · AUM growth acceleration signals
Management guided 8–10% AUM growth for FY27. Q1 delivered 4% (shortfall likely). Watch Q2–Q3 for whether disbursement momentum and product diversification can shift the portfolio growth trajectory toward 8–10%. If not, growth story remains broken.
5 · NIM trajectory validation
Guided 2.6% for FY27; Q1 at 2.58%. Watch for Q2 NIM — if it holds above 2.55% or drifts below 2.50%, that signals the severity of the yield gap compression. This is the number that sets the earnings ceiling.
The honest read
LIC Housing's Q1 is a textbook case of headline beat / operational miss. PAT rose 9.9%, but that was credit cost relief, not operational leverage. Revenue fell 2.3%. NIM compressed 10 bps and is already at the lower end of guidance. The portfolio is growing at 4%, half the pace of peers. The stock fell 6.6% by day 5, and at -16.6% from ATH, it's now repricing from 'growth' to 'steady.' This is not a broken franchise. Asset quality is improving, disbursement is strong, and the company is investing in diversification and technology. But it's a company fighting structural headwinds — margin compression from bank competition, a rate-cut cycle that's compressing new-business yields, and a portfolio that's not expanding at the pace the market expects from a housing financer in a growing economy. Management has been honest about the challenge: they've hedged guidance, called the outlook 'challenging,' and reset growth expectations lower. That credibility — saying 'it's tough' rather than 'it's fine' — is the one positive for a buyer at these levels. But near-term upside is capped. The stock is worth owning if you're a patient holder willing to accept 2–3% annual earnings growth and wait for diversification payoff over 18–24 months. It's not worth chasing at current levels if you're looking for earnings acceleration or multiple re-rating. The single number to track from here: NIM. If it can stabilize above 2.55% despite the 87-basis-point yield gap, management's diversification strategy is working and the stock deserves 10–12% upside. If it drifts below 2.50%, margin pressure is winning, and the stock likely re-rates lower. Q2 will tell.